EN / CN

News

Current Position: Home ››  News

Li Xiang, Deputy Director of the Provincial Department of Industry and Information Technology, Visits Newland Pharmaceutical for Research

Release Date:2025-02-08 11:03:10    Views:5048

  On the morning of February 7, Li Xiang, Member of the Party Leadership Group and Deputy Director of the Provincial Department of Industry and Information Technology, led a delegation to the company to investigate the resumption of work and production after the holiday and the operation of the industrial economy. The delegation was accompanied by Zhao Shuhong, Deputy Mayor of Xuchang City, along with leaders from the Municipal Bureau of Industry and Information Technology and the Changge Economic Development Zone, and was received by Xie Jianzhong, Chairman of the Company, and Zhang Luwei, General Manager.

  The research group entered the workshops to inspect production and visited the construction site of a new project to learn about its progress. Chairman Xie Jianzhong accompanied the visit, briefing the group along the way. At the bustling production site, Chairman Xie reported that the company had achieved an auspicious start in both production and sales in January, with the entire company brimming with confidence and pressing ahead with full momentum toward its quarterly and annual targets. At the new project workshop, Chairman Xie introduced the project's construction progress and its broad prospects, stating that the company would make every effort to complete the project and bring it into operation at the earliest opportunity — adding new momentum to the company's high-quality development and contributing new strength to Xuchang's economic growth.

  Deputy Director Li Xiang and his delegation listened carefully to the briefings, and through the close-up on-site visit expressed recognition and praise for the company's development and achievements, congratulating the company on its auspicious start in January. Deputy Director Li expressed the hope that the company would continue to uphold its spirit of practical work and innovation, build on its momentum to deliver strong performance throughout the year, and steadily achieve ever greater progress and accomplishments in the pharmaceutical industry.